Analyst Ratings for Catalyst Pharmaceutical Partners (CPRX) [Buys]
CPRX Rating Summary
CPRX Price Target Summary
- Highest: $34.00 (Cantor Fitzgerald)
- Lowest: $15.50 (Roth/MKM)
- Average: $25.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$25.75 (+75.4%)
* Over Last 12-Mos
Rating Score: 9 / 10
Percentile Rank: 90%
Avg. $ Target:
$25.75 (+75.4%)
* Over Last 12-Mos
Rating Score: 9 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/14/2024 | Citi | Samantha Semenkow | New Coverage | Buy (N/A) |
27.00 (N/A) |
16.62 (14.68) |
-11.67% | Details |
| 3/7/2024 | BofA Securities | Jason M. Gerberry | New Coverage | Buy (N/A) |
23.00 (N/A) |
15.86 (14.68) |
-7.44% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
